Category: Drug Discovery
Drug Discovery market research reports by Icon Group International, Inc.
-
The 2025-2030 World Outlook for Preclinical Imaging (In-VIVO)
The 2025-2030 World Outlook for Preclinical Imaging (In-VIVO) This study covers the world outlook for preclinical imaging (in-VIVO) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More
-
The 2025-2030 World Outlook for Early Toxicity Testing
The 2025-2030 World Outlook for Early Toxicity Testing This study covers the world outlook for early toxicity testing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More
-
The 2025-2030 World Outlook for Onychomycosis (Tinea Unguium) Drugs
The 2025-2030 World Outlook for Onychomycosis (Tinea Unguium) Drugs This study covers the world outlook for onychomycosis (tinea unguium) drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country ... Read More
-
The 2025-2030 World Outlook for Brain Tumor Diagnosis and Therapeutics
The 2025-2030 World Outlook for Brain Tumor Diagnosis and Therapeutics This study covers the world outlook for brain tumor diagnosis and therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the co ... Read More
-
The 2025-2030 World Outlook for HIV and AIDS Therapeutics
The 2025-2030 World Outlook for HIV and AIDS Therapeutics This study covers the world outlook for HIV and AIDS therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mill ... Read More
-
The 2025-2030 World Outlook for Hodgkins Lymphoma Drugs
The 2025-2030 World Outlook for Hodgkins Lymphoma Drugs This study covers the world outlook for Hodgkins lymphoma drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More
-
The 2025-2030 World Outlook for Blood-Product Hematology Drugs
The 2025-2030 World Outlook for Blood-Product Hematology Drugs This study covers the world outlook for blood-product hematology drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in questio ... Read More
-
The 2025-2030 World Outlook for Fibromyalgia Therapeutics
The 2025-2030 World Outlook for Fibromyalgia Therapeutics This study covers the world outlook for fibromyalgia therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mill ... Read More
-
The 2025-2030 World Outlook for HIV Drugs
The 2025-2030 World Outlook for HIV Drugs This study covers the world outlook for HIV drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the perce ... Read More
-
The 2025-2030 World Outlook for RNA-Based Therapeutics and Vaccines
The 2025-2030 World Outlook for RNA-Based Therapeutics and Vaccines This study covers the world outlook for RNA-based therapeutics and vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country ... Read More
-
The 2025-2030 World Outlook for Viral Infection Treatments
The 2025-2030 World Outlook for Viral Infection Treatments This study covers the world outlook for viral infection treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More
-
The 2025-2030 World Outlook for Cushing's Syndrome Diagnostics
The 2025-2030 World Outlook for Cushing's Syndrome Diagnostics This study covers the world outlook for Cushing's syndrome diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in questio ... Read More
-
The 2025-2030 World Outlook for Sleep Aids
The 2025-2030 World Outlook for Sleep Aids This study covers the world outlook for sleep aids across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the per ... Read More
-
The 2025-2030 World Outlook for Botulinum Toxins
The 2025-2030 World Outlook for Botulinum Toxins This study covers the world outlook for botulinum toxins across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dolla ... Read More
-
The 2025-2030 World Outlook for Dyslipidemia Therapeutics
The 2025-2030 World Outlook for Dyslipidemia Therapeutics This study covers the world outlook for dyslipidemia therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mill ... Read More
-
The 2025-2030 World Outlook for Rheumatoid Arthritis Pharmaceutical Therapeutics
The 2025-2030 World Outlook for Rheumatoid Arthritis Pharmaceutical Therapeutics This study covers the world outlook for rheumatoid arthritis pharmaceutical therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings ... Read More
-
The 2025-2030 World Outlook for Orphan Drugs
The 2025-2030 World Outlook for Orphan Drugs This study covers the world outlook for orphan drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the ... Read More
-
The 2025-2030 World Outlook for Precision Medicine (Diagnostics-Therapeutics)
The 2025-2030 World Outlook for Precision Medicine (Diagnostics-Therapeutics) This study covers the world outlook for precision medicine (diagnostics-therapeutics) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E ... Read More
-
The 2025-2030 World Outlook for Ophthalmic Drugs
The 2025-2030 World Outlook for Ophthalmic Drugs This study covers the world outlook for ophthalmic drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dolla ... Read More
-
The 2025-2030 World Outlook for Psoriatic Arthritis Treatments
The 2025-2030 World Outlook for Psoriatic Arthritis Treatments This study covers the world outlook for psoriatic arthritis treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in questio ... Read More
-
The 2025-2030 World Outlook for Psoriasis Treatments
The 2025-2030 World Outlook for Psoriasis Treatments This study covers the world outlook for psoriasis treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U. ... Read More
-
The 2025-2030 World Outlook for Psoriasis Drugs
The 2025-2030 World Outlook for Psoriasis Drugs This study covers the world outlook for psoriasis drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars ... Read More
-
The 2025-2030 World Outlook for Innovative Peptide Therapeutics
The 2025-2030 World Outlook for Innovative Peptide Therapeutics This study covers the world outlook for innovative peptide therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More
-
The 2025-2030 World Outlook for Gonorrhea Therapeutics
The 2025-2030 World Outlook for Gonorrhea Therapeutics This study covers the world outlook for gonorrhea therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More
-
The 2025-2030 World Outlook for Tuberculosis Therapeutics
The 2025-2030 World Outlook for Tuberculosis Therapeutics This study covers the world outlook for tuberculosis therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mill ... Read More
Research Assistance
